Theo Lorenzini

6PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study.

|Apr 03, 2025
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann

|Jul 03, 2023
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.

Theo Lorenzini, Bruno L Cadilha, Hannah Obeck

|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.

Florian Märkl, Mohamed-Reda Benmebarek, Julius Keyl

|Mar 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.

Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier

|Jun 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors.

Bruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman

Pageof 1

Frequent Collaborators

5 joint publications

Sebastian Kobold

5 joint publications

Florian Märkl

4 joint publications

Matthias Seifert

4 joint publications

Ruth Grünmeier